Skip navigation

Driving Value Creation and Risk-Balanced R&D Productivity through Operational Excellence and Asset Development Strategy

August 8-9, 2017
  • Cambridge, MA

Subha B. Basu, PhD, MBA
Managing Director
Converge Advisory Group

Michael Ferrante
Director, R&D Business Operations
Bristol-Myers Squibb

Chris Franco, PhD
Director, Global Portfolio Strategy
Takeda

Emily Gros
Head, Business Information Reporting and Analytics
Astellas

Kenneth I. Kaitin, PhD
Professor of Medicine and Director, Tufts Center for the Study of Drug Development
Tufts University School of Medicine

Ivan Kugener, MD
Vice President, Global Head of Portfolio Management, Valuation and Analytics
EMD Serono

Wendi Lau
Executive Director Business Operations & Portfolio Analytics, Development
Astellas Pharma Global Development

Rob Liebman, MBA
Managing Director
Converge Advisory Group

Leslie Lippard
Associate Director, Pipeline and Portfolio Planning
Genentech

Wayne Mackey
Principal
Product Development Consulting, Inc.

Grace Nakayama, PhD, PMP
Senior Manager, Program Management
Intercept Pharmaceuticals

Soomin Park
Managing Director, Lilly Chorus
Eli Lilly and Company

Rushi Potdar, MD, MBA
Director, R&D Strategy & Business Operations
Johnson & Johnson Medical Devices

Peter Ray
Executive Director, Corporate Strategy
Celgene

Daniel Rosan
Director, R&D Resource and Performance Management
Biogen

Subha B. Basu, PhD, MBA
Managing Director
Converge Advisory Group

Michael Ferrante
Director, R&D Business Operations
Bristol-Myers Squibb

Chris Franco, PhD
Director, Global Portfolio Strategy
Takeda

Emily Gros
Head, Business Information Reporting and Analytics
Astellas

Kenneth I. Kaitin, PhD
Professor of Medicine and Director, Tufts Center for the Study of Drug Development
Tufts University School of Medicine

Ivan Kugener, MD
Vice President, Global Head of Portfolio Management, Valuation and Analytics
EMD Serono

Wendi Lau
Executive Director Business Operations & Portfolio Analytics, Development
Astellas Pharma Global Development

Rob Liebman, MBA
Managing Director
Converge Advisory Group

Leslie Lippard
Associate Director, Pipeline and Portfolio Planning
Genentech

Wayne Mackey
Principal
Product Development Consulting, Inc.

Grace Nakayama, PhD, PMP
Senior Manager, Program Management
Intercept Pharmaceuticals

Soomin Park
Managing Director, Lilly Chorus
Eli Lilly and Company

Rushi Potdar, MD, MBA
Director, R&D Strategy & Business Operations
Johnson & Johnson Medical Devices

Peter Ray
Executive Director, Corporate Strategy
Celgene

Daniel Rosan
Director, R&D Resource and Performance Management
Biogen